Filing Details

Accession Number:
0000711377-16-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-16 20:00:43
Reporting Period:
2016-11-14
Filing Date:
2016-11-16
Accepted Time:
2016-11-16 20:00:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-14 18,000 $28.67 904,212 No 4 M Direct
Common Stock Acquisiton 2016-11-14 18,000 $36.07 922,212 No 4 M Direct
Common Stock Disposition 2016-11-14 36,000 $61.00 886,212 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2016-11-14 18,000 $0.00 18,000 $28.67
Common Stock Common Stock (Right to Buy) Disposition 2016-11-14 18,000 $0.00 18,000 $36.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
339,001 2017-10-04 No 4 M Direct
339,001 2018-08-30 No 4 M Direct
Footnotes
  1. Options were granted 10/4/2012, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
  2. Options were granted 8/30/2013, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant